CARD15 antibody

貨號 Cat. No.
ab52828
規格 Size
100 µl
品牌 Brand
Abcam

Description

CARD15 antibody (ab52828) datasheet


*  Order a unit now and get it with two days























































































Product Name 



CARD15 antibody



Product type 



Primary antibodies



Description 



Mouse polyclonal to CARD15



Immunogen 



Recombinant fragment: SHLARRLLDT VWNKGTWACQ KLIAAAQEAQ ADSQSPKLHG CWDPHSLHPA RDLQSHRPAI VRRLHSHVEN MLDLAWERGF VSQYECDEIR LPIFTPSQRA , corresponding to amino acids 82-181 of Human CARD15

BLAST 'SHLARRLLDT VWNKGTWACQ KLIAAAQEAQ ADSQSPKLHG CWDPHSLHPA RDLQSHRPAI VRRLHSHVEN MLDLAWERGF VSQYECDEIR LPIFTPSQRA'



Reacts with 



Hu


Tested applications

WB



Application notes

Recommended dilutions

WB: 1/1000. Predicted molecular weight: 115 kDa.

This antibody has been tested in Western blot against an E.coli lysate containing the partial recombinant fusion protein used as an immunogen. We have no data on detection of endogenous protein.





Not yet tested in other applications.

Optimal dilutions/concentrations should be determined by the end user.



Cellular localization 



Cytoplasmic



Relevance 


CARD15 (Nod2) is a member of the Nod1/Apaf-1 family of intracellular proteins that contain an N-terminal caspase recruitment domain (CARD), a centrally located nucleotide-binding domain (NBD), and a C-terminal regulatory domain. CARD15 induces NF-kappa-B via RICK (CARDIAK, RIP2) and IKK-gamma. It also confers responsiveness to intracellular bacterial lipopolysaccharides (LPS). Unlike Nod1, this homologue is primary expressed in monocytes. Defects in CARD15 are associated with Blau Syndrome (BS) and Crohn's Disease (CD), and are a cause of susceptibility to ulcerative colitis.



This antibody was raised by a genetic immunization technique. Genetic immunization can be used to generate antibodies by directly delivering antigen-coding DNA into the animal, rather than injecting a protein or peptide (Tang et al. PubMed: 1545867; Chambers and Johnston PubMed 12910245; Barry and Johnston PubMed: 9234514). The animal's cells produce the protein, which stimulates the animal's immune system to produce antibodies against that particular protein.

A vector coding for a partial fusion protein was used for genetic immunisation of a mouse and the resulting serum was tested in Western blot against an E.coli lysate containing that partial fusion protein.

Genetic immunization offers enormous advantages over the traditional protein-based immunization method. DNA is faster, cheaper and easier to produce and can be produced by standard techniques readily amenable to automation. Furthermore, the antibodies generated by genetic immunization are usually of superior quality with regard to specificity, affinity and recognizing the native protein.

Raised in 



Mouse



Clonality 



Polyclonal



Isotype 



IgG



Purity 



Whole antiserum


Storage buffer

Preservative: None

Constituents: 50% Glycerol


Material safety datasheet (MSDS) for this product:

Glycerol MSDS



Form 



Liquid



Concentration 



Concentration not determined

- why is this?



Storage instructions 



Store at -20°C. Stable for 12 months at -20°C


 

CARD15 antibody images:




Product image  Western blot - CARD15 antibody (ab52828)


Western blot - CARD15 antibody (ab52828)

All lanes : CARD15 antibody (ab52828) at 1/1000 dilution



Lane 1 : (Left) a total protein extract from E coli with 50ng to 100 ng of a tagged fusion protein of an irrelevant antigen

Lane 2 : (Right) a total protein extract from E coli with 50ng to 500ng of the antigen (tagged antigen fusion protein)



Lysates/proteins at 20 µg per lane.



Secondary

Rabbit anti-mouse IgG + IgM, (H+L) horseradish peroxidase at 1/5000 dilution



Predicted band size : 115 kDa

 




詢價 / 洽詢此產品

同品牌其他產品

回到產品列表

▲ LINE
諮詢